Category: Other

Fed shouldn’t rush to cut rate in 2007

The Federal Open-Market Committee’s decision Tuesday to leave its target interest rate unchanged surprised no one. Under Alan Greenspan, it adopted a practice of changing course only after prior warning. It had not given such hints after its November meeting.…

Immigration reform complex

The coordinated raids Tuesday on Swift & Co. packing plants in Worthington, Minn. and five other cities around the country highlight the inherent complications of immigration reform. In each case, large numbers of federal officers led by Immigration and Customs…

Politics can scuttle Fed’s mission

History has demonstrated repeatedly that when a nation’s money supply is subordinated to politics, inflation results and society suffers. The United States structured the Federal Reserve to minimize political tinkering. But elected officials still pressure Fed decision makers to manipulate…

Price laws are useless relics of New Deal

Institutions and laws often outlive the problems they were created to solve — even when they were bad in the first place. Thomas Hobbes, the 17th-century English philosopher, famously described the politicized Renaissance papacy as “the ghost of the deceased…

How cost-efficient is NATO?

Collective-security agreements like NATO can foster efficient use of resources for national defense. However, member nations of such organizations may be tempted to free-ride on the expenditures of others. President Jimmy Carter struggled with this problem 27 years ago, and…

Policy stymied by politics in U.S., China

U.S. election news overshadowed an extraordinary announcement by China last week: Its holdings of foreign currencies passed $1 trillion. Much of the hoard consists of U.S. dollars, most of which are lent back to the U.S. government. This unprecedented development…

Is drug-cost bargaining sound policy?

When Congress passed the Medicare Prescription Drug Improvement and Modernization Act in 2003, it specifically banned the Social Security Administration from negotiating preferential prices with drug companies. The new Democratic majority in Congress wants to change that. Indeed, removing that…